New and updated preclinical and clinical data presented by biopharma firms at the American Diabetes Association's 80th Scientific Sessions, including: Cirius, Diasome, Dompé, Hua, Lilly, Mannkind, Novo, Oramed, Vtv, Xeris, Zealand.